Phathom Pharmaceuticals is a biopharmaceutical company focused on transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights to vonoprazan, a novel potassium-competitive acid blocker, in the U.S., Europe, and Canada, Phathom aims to change the landscape of acid-related disorders while advancing a pipeline of innovative treatments for conditions like Eosinophilic Esophagitis.
No jobs found. Subscribe below to get notified when we find something for you.
Searching